α-melanocyte-stimulating hormone and related tripeptides: Biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases

Endocrine Reviews

Volumn 29, Issue 5, 2008, Pages 581-602

  Brzoska, Thomas ^a,b   Luger, Thomas A ^a   Maaser, Christian ^a   Abels, Christoph ^b   Böhm, Markus ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Wolff Arzneimittel   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; BLEOMYCIN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; CORTICOTROPIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; LYSYLPROLYLTHREONINE; LYSYLPROLYLVALINE; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; MELANOCORTIN RECEPTOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; PREDNISOLONE; PROOPIOMELANOCORTIN; PYROGEN; TRIPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; APOPTOSIS; ARTHRITIS; BIOCHEMISTRY; CELL MIGRATION; CELL PROTECTION; COLITIS; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM INFLAMMATION; ENCEPHALITIS; ENDOTOXEMIA; EYE INFLAMMATION; FEVER; FIBROSIS; HEART MUSCLE ISCHEMIA; HEPATITIS; HUMAN; HUMAN CELL; IMMUNE MEDIATED INJURY; INFLAMMATORY CELL; INFLAMMATORY DISEASE; IRRITANT DERMATITIS; LYMPHOCYTE PROLIFERATION; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OTOTOXICITY; PANCREATITIS; PERITONITIS; PIGMENTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCLERODERMA; SHWARTZMAN PHENOMENON; SIDE EFFECT; SKIN ALLERGY; T LYMPHOCYTE ACTIVATION; UVEITIS; VASCULITIS; WEIGHT REDUCTION;

ALPHA-MSH; AMINO ACID SEQUENCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATION; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 49449094104     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2007-0027     Document Type: Review

References (196)

1. Lipton JM, Catania A 1997 Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol Today 18:140-145
2. Getting SJ 2006 Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther 111:1-15
3. Luger TA, Scholzen TE, Brzoska T, Böhm M 2003 New insights into the functions of α-MSH and related peptides in the immune system. Ann NY Acad Sci 994:133-140
4. Eipper BA, Mains RE 1980 Structure and biosynthesis of proadrenocorticortropin/endorphin and related peptides. Endocr Rev 1:1-27
5. Seidah NG, Benjannet S, Hamelin J, Mamarbachi AM, Basak A, Marcinkiewicz J, Mbikay M, Chretien M, Marcinkiewicz M 1999 The subtilisin/kexin family of precursor convertases. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SKI-1. Ann NY Acad Sci 885:57-74
6. Slominski A, Wortsman J, Luger T, Paus R, Solomon S 2000 Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 80:979-1020
7. Böhm M, Luger TA, Tobin DJ, Garcia-Borrón JG 2006 Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol 126:1966-1975
8. Hruby VJ, Wilkes BC, Hadley ME, Al-Obeidi F, Sawyer TK, Staples DJ, de Vaux AE, Dym O, Castrucci AM, Hintz MF, Riehm JP, Rao KR 1987 α-Melanotropin: the minimal active sequence in the frog skin bioassay. J Med Chem 30:2126-2130
9. Haskell-Luevano C, Sawyer TK, Hendrata S, North C, Panahinia L, Stum M, Staples DJ, Castrucci AM, Hadley MF, Hruby VJ 1996 Truncation studies of α-melanotropin peptides identify tripeptide analogues exhibiting prolonged agonist bioactivity. Peptides 17:995-1002
10. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD 1992 The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248-1251
11. Cone RD, Lu D, Koppula S, Vage DI, Klungland H, Boston B, Chen W, Orth DN, Pouton C, Kesterson RA 1996 The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res 51:287-318
12. Schiöth HB, Muceniece R, Larsson M, Mutulis F, Szardenings M, Prusis P, Lindeberg G, Wikberg JE 1997 Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. J Pharmacol 319:369-373
13. Elliott RJ, Szabo M, Wagner MJ, Kemp EH, MacNeil S, Haycock JW 2004 α-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J Invest Dermatol 122:1010-1019
14. Englaro W, Rezzonico R, Durand-Clement M, Lallemand D, Ortonne JP, Ballotti R 1995 Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem 270:24315-24320
15. An JJ, Rhee Y, Kim SH, Kim DM, Han DH, Hwang JH, Jin YJ, Cha BS, Baik JH, Lee WT, Lim SK 2007 Peripheral effect of α-melanocyte-stimulating hormone on fatty acid oxidation in skeletal muscle. J Biol Chem 282:2862-2867
16. Colombo G, Buffa R, Bardella MT, Garofalo L, Carlin A, Lipton JM, Catania A 2002-2003 Anti-inflammatory effects of α-melanocyte- stimulating hormone in celiac intestinal mucosa. Neuroimmunomodulation 10:208-216
17. Bhardwaj R, Becher E, Mahnke K, Hartmeyer M, Schwarz T, Scholzen T, Luger TA 1997 Evidence for the differential expression of the functional α-melanocyte-stimulating hormone receptor MC-1 on human monocytes. J Immunol 158:3378-3384
18. Cooper A, Robinson SJ, Pickard C, Jackson CL, Friedmann PS, Healy E 2005 α-Melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status. J Immunol 175:4806-4813
19. Andersen GN, Hagglund M, Nagaeva O, Frangsmyr L, Petrovska R, Mincheva-Nilsson L, Wikberg JE 2005 Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opiomelanocortin peptide gene expression in subsets of human peripheral blood leucocytes. Scand J Immunol 61:279-284
20. Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JM 1996 The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17:675-679
21. Mugridge KG, Perretti M, Ghiara P, Parente L 1991 α-Melanocyte-stimulating hormone reduces interleukin-1β effects on rat stomach preparations possibly through interference with a type I receptor. Eur J Pharmacol 197:151-155
22. Poole S, Bristow AF, Lorenzetti BB, Das RE, Smith TW, Ferreira SH 1992 Peripheral analgesic activities of peptides related to α-melanocyte stimulating hormone and interleukin-1β 193-195. Br J Pharmacol 106:489-492
23. Getting SJ, Schiöth HB, Perretti M 2003 Dissection of the antiinflammatory effect of the core and C-terminal (KPV) α-melanocyte- stimulating hormone peptides. J Pharmacol Exp Ther 306:631-637
24. Ichiyama T, Sakai T, Catania A, Barsh GS, Furukawa S, Lipton JM 1999 Inhibition of peripheral NF-κB activation by central action of α-melanocyte-stimulating hormone. J Neuroimmunol 99:211-217
25. Bhardwaj R, Hadley ME, Dorr RT, Dvorakova K, Brooks C, Blanchard J 2000 Pharmacologic response of a controlled-release PLGA formulation for the α-melanocyte stimulating hormone analog, melanotan-I. Pharm Res 17:593-599
26. Tatro JB, Entwistle ML 1994 Heterogeneity of brain melanocortin receptors suggested by differential ligand binding in situ. Brain Res 635:148-158
27. Lyson K, Ceriani G, Takashima A, Catania A, Lipton JM 1994 Binding of antiinflammatory α-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells. Neuroimmunomodulation 1:121-126
28. Mandrika I, Muceniece R, Wikberg JE 2001 Effects of melanocortin peptides on lipopolysaccharide/interferon-γ-induced NF-κB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action. Biochem Pharmacol 61:613-621
29. Delgado R, Carlin A, Airaghi L, Demitri MT, Meda L, Galimberti D, Baron P, Lipton JM, Catania A 1998 Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J Leukoc Biol 63:740-745
30. Dalmasso G, Charrier-Hisamuddin L, Thu Nguyen HT, Yan Y, Sitaraman S, Merlin D 2008 PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 134:166-178
31. Taylor AW, Streilein JW, Cousins SW 1992 Identification of α-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 11:1199-1206
32. Taylor AW, Streilein JW, Cousins SW 1994 α-Melanocyte- stimulating hormone suppresses antigen-stimulated T cell production of γ-interferon. Neuroimmunomodulation 1:188-194
33. Luger TA, Schauer E, Trautinger F, Krutmann J, Ansel J, Schwarz A, Schwarz T 1993 Production of immunosuppressive melanotropins by human keratinocytes. Ann NY Acad Sci 680:567-570
34. Wong KY, Rajora N, Boccoli G, Catania A, Lipton JM 1997 A potential mechanism of local anti-inflammatory action of α-melanocyte- stimulating hormone within the brain: modulation of tumor necrosis factor-α production by human astrocytic cells. Neuroimmunomodulation 4:37-41
35. Rajora N, Boccoli G, Burns D, Sharma S, Catania AP, Lipton JM 1997 α-MSH modulates local and circulating tumor necrosis factor-α in experimental brain inflammation. J Neurosci 17:2181-2186
36. Galimberti D, Baron P, Meda L, Prat E, Scarpini E, Delgado R, Catania A, Lipton JM, Scarlato G 1999 α-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-α by microglial cells activated with β-amyloid and interferon γ. Biochem Biophys Res Commun 263:251-256
37. Taherzadeh S, Sharma S, Chhajlani V, Gantz I, Rajora N, Demitri MT, Kelly L, Zhao H, Ichiyama T, Catania A, Lipton JM 1999 α-MSH and its receptors in regulation of tumor necrosis factor-α production by human monocyte/macrophages. Am J Physiol 276:R1289-R1294
38. Adachi S, Nakano T, Vliagoftis H, Metcalfe DD 1999 Receptor-mediated modulation of murine mast cell function by α-melanocyte stimulating hormone. J Immunol 163:3363-3368
39. Chiao H, Kohda Y, McLeroy P, Craig L, Linas S, Star RA 1998 α-Melanocyte-stimulating hormone inhibits renal injury in the absence of neutrophils. Kidney Int 54:765-774
40. Böhm M, Schulte U, Kalden H, Luger TA 1999 α-Melanocyte-stimulating hormone modulates activation of NF-κB and AP-1 and secretion of interleukin-8 in human dermal fibroblasts. Ann NY Acad Sci 885:277-286
41. Brzoska T, Kalden DH, Scholzen T, Luger TA 1999 Molecular basis of the α-MSH/IL-1 antagonism. Ann NY Acad Sci 885:230-238
42. Böhm M, Schiller M, Ständer S, Seltmann H, Li Z, Brzoska T, Metze D, Schiöth HB, Skottner A, Seiffert K, Zouboulis CC, Luger TA 2002 Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 118:533-539
43. Holdeman M, Lipton JM 1985 Antipyretic activity of a potent α-MSH analog. Peptides 6:273-275
44. Manna SK, Sarkar A, Sreenivasan Y 2006 α-Melanocyte- stimulating hormone down-regulates CXC receptors through activation of neutrophil elastase. Eur J Immunol 36:754-769
45. Bhardwaj RS, Schwarz A, Becher E, Mahnke K, Aragane Y, Schwarz T, Luger TA 1996 Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 156:2517-2521
46. Redondo P, Garcia-Foncillas J, Okroujnov I, Bandres E 1998 α-MSH regulates interleukin-10 expression by human keratinocytes. Arch Dermatol Res 290:425-428
47. Morandini R, Boeynaems JM, Hedley SJ, MacNeil S, Ghanem G 1998 Modulation of ICAM-1 expression by α-MSH in human melanoma cells and melanocytes. J Cell Physiol 175:276-282
48. Kalden DH, Scholzen T, Brzoska T, Luger TA 1999 Mechanisms of the antiinflammatory effects of α-MSH. Role of transcription factor NF-κB and adhesion molecule expression. Ann NY Acad Sci 885:254-261
49. Scholzen TE, Sunderkötter C, Kalden DH, Brzoska T, Fastrich M, Fisbeck T, Armstrong CA, Ansel JC, Luger TA 2003 α-Melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 144:360-370
50. Böhm M, Eickelmann M, Li Z, Schneider SW, Oji V, Diederichs S, Barsh GS, Vogt A, Stieler K, Blume-Peytavi U, Luger TA 2005 Detection of functionally active melanocortin receptors and evidence for an immunoregulatory activity of α-melanocyte-stimulating hormone in human dermal papilla cells. Endocrinology 146:4635-4646
51. Hill RP, MacNeil S, Haycock JW 2006 Melanocyte stimulating hormone peptides inhibit TNF-α signaling in human dermal fibroblast cells. Peptides 27:421-430
52. Sarkar A, Sreenivasan Y, Manna SK 2003 α-Melanocyte- stimulating hormone induces cell death in mast cells: involvement of NF-κB. FEBS Lett 549:87-93
53. Becher E, Mahnke K, Brzoska T, Kalden DH, Grabbe S, Luger TA 1999 Human peripheral blood-derived dendritic cells express functional melanocortin receptor MC-1R. Ann NY Acad Sci 885:188-195
54. Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, Paus R 2004 Collapse and restoration of MHC class I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 164:623-634
55. Cannon JG, Tatro JB, Reichlin S, Dinarello CA 1986 α-Melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol 137:2232-2236
56. Nicolaou A, Estdale SE, Tsatmali M, Herrero DP, Thody AJ 2004 Prostaglandin production by melanocytic cells and the effect of α-melanocyte stimulating hormone. FEBS Lett 570:223-226
57. Star RA, Rajora N, Huang J, Stock RC, Catania A, Lipton JM 1995 Evidence of autocrine modulation of macrophage nitric oxide synthase by α-melanocyte-stimulating hormone. Proc Natl Acad Sci USA 92:8016-8020
58. Tsatmali M, Graham A, Szatkowski D, Ancans J, Manning P, McNeil CJ, Graham AM, Thody AJ 2000 α-Melanocyte-stimulating hormone modulates nitric oxide production in melanocytes. J Invest Dermatol 114:520-526
59. Gupta AK, Diaz RA, Higham S, Kone BC 2000 α-MSH inhibits induction of C/EBPβ-DNA binding activity and NOS2 gene transcription in macrophages. Kidney Int 57:2239-2248
60. Caruso C, Durand D, Schiöth HB, Rey R, Seilicovich A, Lasaga M 2007 Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-γ in astrocytes. Endocrinology 148:4918-4926
61. Jung EJ, Han DJ, Chang SH, Lim DG, Wee YM, Kim JH, Kim YH, Koo SK, Choi M, Kim SC 2007 Protective effect of α-melanocyte-stimulating hormone on pancreas islet cell against peripheral blood mononuclear cell-mediated cytotoxicity in vitro. Transplant Proc 39:1604-1606
62. Rajora N, Ceriani G, Catania A, Star RA, Murphy MT, Lipton JM 1996 α-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J Leukoc Biol 59:248-253
63. Oktar BK, Yuksel M, Alican I 2004 The role of cyclooxygenase inhibition in the effect of α-melanocyte-stimulating hormone on reactive oxygen species production by rat peritoneal neutrophils. Prostaglandins Leukot Essent Fatty Acids 71:1-5
64. Nishida T, Taylor AW 1999 Specific aqueous humor factors induce activation of regulatory T cells. Invest Ophthalmol Vis Sci 40:2268-2274
65. Aberdam E, Auberger P, Ortonne JP, Ballotti R 2000 Neprilysin, a novel target for ultraviolet B regulation of melanogenesis via melanocortins. J Invest Dermatol 115:381-387
66. Namba K, Kitaichi N, Nishida T, Taylor AW 2002 Induction of regulatory T cells by the immunomodulating cytokines α-melanocyte- stimulating hormone and transforming growth factor-β2. J Leukoc Biol 72:946-952
67. Rees JL 2003 Genetics of hair and skin color. Annu Rev Genet 37:67-90
68. Healy E, Jordan SA, Budd PS, Suffolk R, Rees JL, Jackson IJ 2001 Functional variation of MC1R alleles from red-haired individuals. Hum Mol Genet 10:2397-2402
69. Schiöth HB, Phillips SR, Rudzish R, Birch-Machin MA, Wikberg JE, Rees JL 1999 Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys Res Commun 260:488-491
70. Manna SK, Aggarwal BB 1998 α-Melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-κB activation induced by various inflammatory agents. J Immunol 161:2873-2880
71. Haycock JW, Wagner M, Morandini R, Ghanem G, Rennie IG, MacNeil S 1999 α-Melanocyte-stimulating hormone inhibits NF-κB activation in human melanocytes and melanoma cells. J Invest Dermatol 113:560-566
72. Moustafa M, Szabo M, Ghanem GE, Morandini R, Kemp EH, MacNeil S, Haycock JW 2002 Inhibition of tumor necrosis factor-α stimulated NFκB/p65 in human keratinocytes by α-melanocyte stimulating hormone and adrenocorticotropic hormone peptides. J Invest Dermatol 119:1244-1253
73. Teare KA, Pearson RG, Shakesheff KM, Haycock JW 2004 α-MSH inhibits inflammatory signalling in Schwann cells. NeuroReport 15:493-498
74. Ichiyama T, Zhao H, Catania A, Furukawa S, Lipton JM 1999 α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation. Exp Neurol 157:359-365
75. Zou L, Sato N, Kone BC 2004 α-Melanocyte stimulating hormone protects against H2O2-induced inhibition of wound restitution in IEC-6 cells via a Syk kinase- and NF-κβ-dependent mechanism. Shock 22:453-459
76. Yoon SW, Chun JS, Sung MH, Kim JY, Poo H 2007 α-MSH inhibits TNF-α-induced matrix metalloproteinase-13 expression by modulating p38 kinase and nuclear factor κB signaling in human chondrosarcoma HTB-94 cells. Osteoarthritis Cartilage 16:115-124
77. Glyn JR, Lipton JM 1981 Hypothermic and antipyretic effects of centrally administered ACTH (1-24) and α-melanotropin. Peptides 2:177-187
78. Glyn-Ballinger JR, Bernardini GL, Lipton JM 1983 α-MSH injected into the septal region reduces fever in rabbits. Peptides 4:199-203
79. Murphy MT, Lipton JM 1982 Peripheral administration of α-MSH reduces fever in older and younger rabbits. Peptides 3:775-779
80. Murphy MT, Richards DB, Lipton JM 1983 Antipyretic potency of centrally administered α-melanocyte stimulating hormone. Science 221:192-193
81. Kandasamy SB, Williams BA 1984 Hypothermic and antipyretic effects of ACTH (1-24) and α-melanotropin in guinea pigs. Neuropharmacology 23:49-53
82. Shih ST, Lipton JM 1985 Intravenous α-MSH reduces fever in the squirrel monkey. Peptides 6:685-687
83. Daynes RA, Robertson BA, Cho BH, Burnham DK, Newton R 1987 α-Melanocyte-stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin 1-inducible responses in vivo and in vitro. J Immunol 139:103-109
84. Deeter LB, Martin LW, Lipton JM 1989 Antipyretic effect of central α-MSH summates with that of acetaminophen or ibuprofen. Brain Res Bull 23:573-575
85. Martin LW, Lipton JM 1990 Acute phase response to endotoxin: rise in plasma α-MSH and effects of α-MSH injection. Am J Physiol 259:R768-R772
86. Feng JD, Dao T, Lipton JM 1987 Effects of preoptic microinjection of α-MSH on fever and normal temperature control in rabbits. Brain Res Bull 18:473-477
87. Rezvani AH, Denbow DM, Myers RD 1986 α-Melanocyte- stimulating hormone infused icv fails to affect body temperature or endotoxin fever in the cat. Brain Res Bull 16:99-105
88. Tatro JB 2000 Endogenous antipyretics. Clin Infect Dis 21:S190-S201
89. Tatro JB 2000 Melanocortin receptor expression and function in the nervous system. In: Cone RD, ed. The melanocortin receptors. Totowa, NJ: Humana Press; 173-207
90. Huang QH, Entwistle ML, Alvaro JD, Duman RS, Hruby VJ, Tatro JB 1997 Antipyretic role of endogenous melanocortins mediated by central melanocortin receptors during endotoxin-induced fever. J Neurosci 17:3343-3351
91. Sinha PS, Schioth HB, Tatro JB 2004 Roles of the melanocortin-4 receptor in antipyretic and hyperthermic actions of centrally administered α-MSH. Brain Res 1001:150-158
92. Greenberg R, Whalley CE, Jourdikian F, Mendelson IS, Walter R, Nikolics K, Coy DH, Schally AV, Kastin AJ 1976 Peptides readily penetrate the blood-brain barrier: uptake of peptides by synaptosomes is passive. Pharmacol Biochem Behav 5(Suppl 1):151-158
93. Tatro JB, Sinha PS 2003 The central melanocortin system and fever. Ann NY Acad Sci 994:246-257
94. Ichiyama T, Sakai T, Catania A, Barsh GS, Furukawa S, Lipton JM 1999 Systemically administered α-melanocyte-stimulating peptides inhibit NF-κB activation in experimental brain inflammation. Brain Res 836:31-37
95. Han D, Tian Y, Zhang M, Zhou Z, Lu J 2007 Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated α-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells. Gene Ther 14:383-395
96. Gonindard C, Goigoux C, Hollande E, D'Hinterland LD 1996 The administration of an α-MSH analogue reduces the serum release of IL-1 α and TNF α induced by the injection of a sublethal dose of lipopolysaccharides in the BALB/c mouse. Pigment Cell Res 9:148-153
97. Lipton JM, Ceriani G, Macaluso A, McCoy D, Carnes K, Biltz J, Catania A 1994 Antiinflammatory effects of the neuropeptide α-MSH in acute, chronic, and systemic inflammation. Ann NY Acad Sci 741:137-148
98. Denko CW, Gabriel P 1985 Effects of peptide hormones in urate crystal inflammation. J Rheumatol 12:971-975
99. Mason MJ, Van Epps D 1989 Modulation of IL-1, tumor necrosis factor, and C5a-mediated murine neutrophil migration by α-melanocyte- stimulating hormone. J Immunol 142:1646-1651
100. Hiltz ME, Lipton JM 1990 α-MSH peptides inhibit acute inflammation and contact sensitivity. Peptides 11:979-982
101. Hiltz ME, Catania A, Lipton JM 1992 α-MSH peptides inhibit acute inflammation induced in mice by rIL-1β, rIL-6, rTNF-α and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. Cytokine 4:320-328
102. Perretti M, Appleton I, Parente L, Flower RJ 1993 Pharmacology of interleukin-1-induced neutrophil migration. Agents Actions 38:C64-C65
103. Watanabe T, Hiltz ME, Catania A, Lipton JM 1993 Inhibition of IL-1β-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide α-MSH. Brain Res Bull 32:311-314
104. Macaluso A, McCoy D, Ceriani G, Watanabe T, Biltz J, Catania A, Lipton JM 1994 Antiinflammatory influences of α-MSH molecules: central neurogenic and peripheral actions. J Neurosci 14:2377-2382
105. Ceriani G, Macaluso A, Catania A, Lipton JM 1994 Central neurogenic antiinflammatory action of α-MSH: modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology 59:138-143
106. Rheins LA, Cotleur AL, Kleier RS, Hoppenjans WB, Saunder DN, Nordlund JJ 1989 α-Melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J Invest Dermatol 93:511-517
107. Grabbe S, Bhardwaj RS, Mahnke K, Simon MM, Schwarz T, Luger TA 1996 α-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol 156:473-478
108. Yamamoto T, Nishioka K 2005 Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective. Exp Dermatol 14:81-95
109. Kokot A, Sindrilaru A, Schiller S, Sunderkötter C, Kerkhoff C, Scharffetter-Kochanek K, Luger TA, Böhm M 2008 ̈-Melanocyte- stimulating hormone is a powerful agent in the bleomycin model of collagen synthesis and fibrosis. Exp Dermatol 17:286(Abstract)
110. Böhm M, Raghunath M, Sunderkötter C, Schiller M, Ständer S, Brzoska T, Cauvet T, Schiöth HB, Schwarz T, Luger TA 2004 Collagen metabolism is a novel target of the neuropeptide α-melanocyte-stimulating hormone. J Biol Chem 279:6959-6966
111. Lee TH, Jawan B, Chou WY, Lu CN, Wu CL, Kuo HM, Concejero AM, Wang CH 2006 α-Melanocyte-stimulating hormone gene therapy reverses carbon tetrachloride induced liver fibrosis in mice. J Gene Med 8:764-772
112. Ceriani G, Diaz J, Murphree S, Catania A, Lipton JM 1994 The neuropeptide α-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1:28-32
113. Getting SJ, Christian HC, Flower RJ, Perretti M 2002 Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 46:2765-2775
114. Taylor AW, Yee DG, Nishida T, Namba K 2000 Neuropeptide regulation of immunity. The immunosuppressive activity of α-melanocyte-stimulating hormone (α-MSH). Ann NY Acad Sci 917:239-247
115. Nishida T, Miyata S, Itoh Y, Mizuki N, Ohgami K, Shiratori K, Ilieva IB, Ohno S, Taylor AW 2004 Anti-inflammatory effects of α-melanocyte- stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor. Int Immunopharmacol 4:1059-1066
116. Naveh N, Marshall J 2001 Melanocortins are comparable to corticosteroids as inhibitors of traumatic ocular inflammation in rabbits. Graefes Arch Clin Exp Ophthalmol 239:840-844
117. Raap U, Brzoska T, Sohl S, Path G, Emmel J, Herz U, Braun A, Luger T, Renz H 2003 α-Melanocyte-stimulating hormone inhibits allergic airway inflammation. J Immunol 171:353-359
118. Jahovic N, Arbak S, Tekeli O, Alican I 2004 α-Melanocyte stimulating hormone has beneficial effects on cerulein-induced acute pancreatitis. Peptides 25:129-132
119. Al-Majed HT, Jones PM, Persaud SJ, Sugden D, Huang GC, Amiel S, Whitehouse BJ 2004 ACTH stimulates insulin secretion from MIN6 cells and primary mouse and human islets of Langerhans. J Endocrinol 180:155-166
120. Chiao H, Foster S, Thomas R, Lipton J, Star RA 1996 α-Melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J Clin Invest 97:2038-2044
121. Rajora N, Boccoli G, Catania A, Lipton JM 1997 α-MSH modulates experimental inflammatory bowel disease. Peptides 18:381-385
122. Oktar BK, Ercan F, Yegen BC, Alican I 2000 The effect of α-melanocyte stimulating hormone on colonic inflammation in the rat. Peptides 21:1271-1277
123. Maaser C, Kannengiesser K, Specht C, Luegering A, Brzoska T, Luger TA, Domschke W, Kucharzik T 2006 Crucial role of the melanocortin receptor MC1R in experimental colitis. Gut 55:1415-1422
124. Strand FL, Zuccarelli LA, Williams KA, Lee SJ, Lee TS, Antonawich FJ, Alves SE 1993 Melanotropins as growth factors. Ann NY Acad Sci 680:29-50
125. Gispen WH 1993 The potential of melanotropins in the treatment of nervous system diseases. Ann NY Acad Sci 680:401-411
126. Van Rijzingen IM, Gispen WH, Spruijt BM 1996 The ACTH (4-9) analog ORG 2766 and recovery after brain damage in animal models - a review. Behav Brain Res 74:1-15
127. Gispen WH, Adan RA 1999 Melanocortins and the treatment of nervous system disease. Potential relevance to the skin? Ann NY Acad Sci 885:342-349
128. Smoorenburg GF, De Groot JC, Hamers FP, Klis SF 1999 Protection and spontaneous recovery from cisplatin-induced hearing loss. Ann NY Acad Sci 884:192-210
129. Sharma HS 2005 Neuroprotective effects of neurotrophins and melanocortins in spinal cord injury: an experimental study in the rat using pharmacological and morphological approaches. Ann NY Acad Sci 1053:407-442
130. Bär PR, Mandys V, Turecek R, Gispen WH 1993 α-Melanocyte-stimulating hormone has protective properties against the toxic effect of cisplatin on cultured dorsal root ganglia. Ann NY Acad Sci 680:649-665
131. Windebank AJ, Smith AG, Russell JW 1994 The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro. Neurology 44:488-494
132. Chai B, Li JY, Zhang W, Newman E, Ammori J, Mulholland MW 2006 Melanocortin-4 receptor-mediated inhibition of apoptosis in immortalized hypothalamic neurons via mitogen-activated protein kinase. Peptides 27:2846-2857
133. Jo SK, Lee SY, Han SY, Cha DR, Cho WY, Kim HK, Won NH 2001 α-Melanocyte stimulating hormone (MSH) decreases cyclosporine a induced apoptosis in cultured human proximal tubular cells. J Korean Med Sci 16:603-609
134. Böhm M, Wolff I, Scholzen TE, Robinson SJ, Healy E, Luger TA, Schwarz T, Schwarz A 2005 α-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 280:5795-5802
135. Kadekaro AL, Kavanagh R, Kanto H, Terzieva S, Hauser J, Kobayashi N, Schwemberger S, Cornelius J, Babcock G, Shertzer HG, Scott G, Abdel-Malek ZA 2005 α-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 65:4292-4299
136. Abdel-Malek ZA, Kadekaro AL, Kavanagh RJ, Todorovic A, Koikov LN, McNulty JC, Jackson PJ, Millhauser GL, Schwemberger S, Babcock G, Haskell-Luevano C, Knittel JJ 2006 Melanoma prevention strategy based on using tetrapeptide α-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity. FASEB J 20:1561-1563
137. Hill RP, Wheeler P, MacNeil S, Haycock JW 2005 α-Melanocyte stimulating hormone cytoprotective biology in human dermal fibroblast cells. Peptides 26:1150-1158
138. Tatro JB 2006 Melanocortins defend their territory: multifaceted neuroprotection in cerebral ischemia. Endocrinology 147:1122-1125
139. Edwards PM, Van der Zee CE, Verhaagen J, Schotman P, Jennekens FG, Gispen WH 1984 Evidence that the neurotrophic actions of α-MSH may derive from its ability to mimick the actions of a peptide formed in degenerating nerve stumps. J Neurol Sci 64:333-340
140. Vadoud Seyedi J, Liénard D, Lespagnard L, Ghanem G, Van Wijck R, Lejeune F 1993 Local administration of α-MSH exerts a trophic effect on the 200-kDa neurofilament in sciatic rat nerve. Ann NY Acad Sci 680:655-659
141. Van de Meent H, Hamers FP, Lankhorst AJ, Joosten EA, Gispen WH 1997 Beneficial effects of the melanocortin α-melanocyte-stimulating hormone on clinical and neurophysiological recovery after experimental spinal cord injury. Neurosurgery 40:122-130
142. Lankhorst AJ, Duis SE, ter Laak MP, Joosten EA, Hamers FP, Gispen WH 1999 Functional recovery after central infusion of α-melanocyte- stimulating hormone in rats with spinal cord contusion injury. J Neurotrauma 16:323-331
143. Joosten EA, Majewska B, Houweling DA, Bär PR, Gispen WH 1999 α-Melanocyte stimulating hormone promotes regrowth of injured axons in the adult rat spinal cord. J Neurotrauma 16:543-553
144. Sharma HS, Skottner A, Lundstedt T, Flärdh M, Wiklund L 2006 Neuroprotective effects of melanocortins in experimental spinal cord injury. An experimental study in the rat using topical application of compounds with varying affinity to melanocortin receptors. J Neural Transm 113:463-476
145. Heijmen PS, Klis SF, De Groot JC, Smoorenburg GF 1999 Cisplatin ototoxicity and the possibly protective effect of α-melanocyte stimulating hormone. Hear Res 128:27-39
146. Wolters FL, Klis SF, de Groot JC, Hamers FP, Prieskorn DM, Miller JM, Smoorenburg GF 2003 Systemic co-treatment with α-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs. Hear Res 179:53-61
147. Hamers FP, Wijbenga J, Wolters FL, Klis SF, Sluyter S, Smoorenburg GF 2003 Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by α-MSH and ORG 2766. Audiol Neurootol 8:305-315
148. Forslin Aronsson A, Spulber S, Oprica M, Winblad B, Post C, Schultzberg M 2007 α-MSH rescues neurons from excitotoxic cell death. J Mol Neurosci 33:239-251
149. Huh SK, Lipton JM, Batjer HH 1997 The protective effects of α-melanocyte stimulating hormone on canine brain stem ischemia. Neurosurgery 40:132-139
150. Huang Q, Tatro JB 2002 α-Melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-α and interleukin-1β gene expression following transient cerebral ischemia in mice. Neurosci Lett 334:186-190
151. Spulber S, Moldovan M, Oprica M, Aronsson AF, Post C, Winblad B, Schultzberg M 2005 α-MSH decreases core and brain temperature during global cerebral ischemia in rats. NeuroReport 16:69-72
152. Forslin Aronsson S, Spulber S, Popescu LM, Winblad B, Post C, Oprica M, Schultzberg M 2006 α-Melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides 40:65-75
153. Giuliani D, Leone S, Mioni C, Bazzani C, Zaffe D, Botticelli AR, Altavilla D, Galantucci M, Minutoli L, Bitto A, Squadrito F, Guarini S 2006 Broad therapeutic treatment window of [Nle(4), D-Phe(7)]α-melanocyte- stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils. Eur J Pharmacol 538:48-56
154. Giuliani D, Ottani A, Mioni C, Bazzani C, Galantucci M, Minutoli L, Bitto A, Zaffe D, Botticelli AR, Squadrito F, Guarini S 2007 Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins. Eur J Pharmacol 570:57-65
155. Giuliani D, Mioni C, Altavilla D, Leone S, Bazzani C, Minutoli L,
156. Vecsernyes M, Juhasz B, Der P, Kocsan R, Feher P, Bacskay I, Kovacs P, Tosaki A 2003 The administration of α-melanocyte-stimulating hormone protects the ischemic/reperfused myocardium. Eur J Pharmacol 470:177-183
157. Bertolini A, Guarini S, Rompianesi E, Ferrari W 1986 α-MSH and other ACTH fragments improve cardiovascular function and survival in experimental hemorrhagic shock. Eur J Pharmacol 130:19-26
158. Guarini S, Schiöth HB, Mioni C, Cainazzo M, Ferrazza G, Giuliani D, Wikberg JE, Bertolini A, Bazzani C 2002 MC(3) receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion- induced arrhythmias. Naunyn Schmiedebergs Arch Pharmacol 366:177-182
159. Mioni C, Giuliani D, Cainazzo MM, Leone S, Bazzani C, Grieco P, Novellino E, Tomasi A, Bertolini A, Guarini S 2004 Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors. Eur J Pharmacol 477:227-234
160. Yamaoka-Tojo M, Tojo T, Shioi T, Masuda T, Inomata T, Izumi T 2006 Central neurotranspeptide, α-melanocyte-stimulating hormone (α-MSH) is upregulated in patients with congestive heart failure. Intern Med 45:429-434
161. Hassoun HT, Zou L, Moore FA, Kozar RA, Weisbrodt NW, Kone BC 2002 α-Melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 282:G1059-G1068
162. Zou L, Sato N, Attuwaybi BO, Kone BC 2003 Delayed administration of α-melanocyte-stimulating hormone or combined therapy with BAY 11-7085 protects against gut ischemia-reperfusion injury. Shock 20:469-475
163. Takahashi T, Shimizu H, Morimatsu H, Inoue K, Akagi R, Morita K, Morita K, Sassa S 2007 Heme-oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation. Mini Rev Med Chem 7:745-753
164. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA 1997 α-Melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 99:1165-1172
165. Jo SK, Yun SY, Chang KH, Cha DR, Cho WY, Kim HK, Won NH 2001 α-MSH decreases apoptosis in ischaemic acute renal failure in rats: possible mechanism of this beneficial effect. Nephrol Dial Transplant 16:1583-1591
166. Kwon TH, Frøkiaer J, Fernández-Llama P, Knepper MA, Nielsen S 1999 Reduced abundance of aquaporins in rats with bilateral ischemia-induced acute renal failure: prevention by α-MSH. Am J Physiol 277:F413-F427
167. Gong H, Wang W, Kwon TH, Jonassen T, Li C, Ring T, Frøkiaer J, Nielsen S 2004 EPO and α-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney Int 66:683-695
168. Lee SY, Jo SK, Cho WY, Kim HK, Won NH 2004 The effect of α-melanocyte-stimulating hormone on renal tubular cell apoptosis and tubulointerstitial fibrosis in cyclosporine A nephrotoxicity. Transplantation 78:1756-1764
169. Kolgazi M, Arbak S, Alican I 2007 The effect of α-melanocyte stimulating hormone on gentamicin-induced acute nephrotoxicity in rats. J Appl Toxicol 27:183-188
170. Li C, Shi Y, Wang W, Sardeli C, Kwon TH, Thomsen K, Jonassen T, Djurhuus JC, Knepper MA, Nielsen S, Frøkiaer J 2006 α-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstruction. Am J Physiol Renal Physiol 290:F384-F396
171. Deng J, Hu X, Yuen PS, Star RA 2004 α-Melanocyte-stimulating hormone inhibits lung injury after renal ischemia/reperfusion. Am J Respir Crit Care Med 169:749-756
172. Colombo G, Gatti S, Sordi A, Turcatti F, Carlin A, Rossi C, Lonati C, Catania A 2007 Production and effects of α-melanocyte-stimulating hormone during acute lung injury. Shock 27:326-333
173. Muceniece R, Krigere L, Suli-Vargha H, Wikberg JE 2003 Effects of α-melanotropin C-terminal tripeptide analogues on macrophage NO production. Peptides 24:701-707
174. Barcellini W, Colombo G, La Maestra L, Clerici G, Garofalo L, Brini AT, Lipton JM, Catania A 2000 α-Melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes. J Leukoc Biol 68:693-699
175. Hiltz ME, Catania A, Lipton JM 1991 Anti-inflammatory activity of α-MSH(11-13) analogs: influences of alteration in stereochemistry. Peptides 12:767-771
176. Haddad JJ, Lauterbach R, Saade NE, Safieh-Garabedian B, Land SC 2001 α-Melanocyte-related tripeptide, Lys-d-Pro-Val, ameliorates endotoxin-induced nuclear factor κB translocation and activation: evidence for involvement of an interleukin-1β 193-195 receptor antagonism in the alveolar epithelium. Biochem J 355:29-38
177. Mastrofrancesco A, Kokot A, Strozyk E, Schiller M, Zouboulis CC, Picardo M, Luger TA, Böhm M 2007 Suppression of inflammatory responses in human sebocyte by K(D)PT, a peptide fragment related to the C-terminal domain of α-melanocyte-stimulating hormone. J Invest Dermatol 127:S70 (Abstract)
178. Richards DB, Lipton JM 1984 Effect of α-MSH 11-13 (lysine-proline-valine) on fever in the rabbit. Peptides 5:815-817
179. Deeter LB, Martin LW, Lipton JM 1989 Antipyretic properties of centrally administered α-MSH fragments in the rabbit. Peptides 9:1285-1288
180. Hiltz ME, Lipton JM 1989 Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide α-MSH. FASEB J 3:2282-2284
181. Kannengiesser K, Maaser C, Heidemann J, Luegering A, Ross M, Brzoska T, Böhm M, Luger TA, Domschke W, Kucharzik T 2008 Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis 14:324-331
182. Maaser C, Bettenworth D, Lügering A, Brzoska T, Luger TA, Domschke W, Kucharzik T 2006 Therapeutischer Einsatz des Tripeptids K(D)PT im murinen DSS-Modell. Z Gastroenterol 44:724 (Abstract)
183. Liang R, Fei YJ, Prasad PD, Ramamoorthy S, Han H, Yang-Feng TL, Hediger MA, Ganapathy V, Leibach FH 1995 Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J Biol Chem 270:6456-6463
184. Ferreira SH, Lorenzetti BB, Bristow AF, Poole S 1988 Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334:698-700
185. Baugh JA, Bucala R 2001 Mechanisms for modulating TNF α in immune and inflammatory disease. Curr Opin Drug Discov Devel 4:635-650
186. Ugwu SO, Blanchard J, Dorr RT, Levine N, Brooks C, Hadley ME, Aickin M, Hruby VJ 1997 Skin pigmentation and pharmacokinetics of melanotan-I in humans. Biopharm Drug Dispos 18:259-269
187. Dorr RT, Dvorakova K, Brooks C, Lines R, Levine N, Schram K, Miketova P, Hruby V, Alberts DS 2000 Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4-D-Phe7]-α-MSH in humans. Photochem Photobiol 72:526-532
188. Dorr RT, Ertl G, Levine N, Brooks C, Bangert JL, Powell MB, Humphrey S, Alberts DS 2004 Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers. Arch Dermatol 140:827-835
189. Hadley ME, Dorr RT 2006 Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides 27:921-930
190. Cutuli M, Cristiani S, Lipton JM, Catania A 2000 Antimicrobial effects of α-MSH peptides. J Leukoc Biol 67:233-239
191. Lipton JM 1990 Modulation of host defense by the neuropeptide α-MSH. Yale J Biol Med 63:173-182
192. Potaman VN, Alfeeva LY, Kamensky AA, Nezavibatko VN 1993 Degradation of ACTH/MSH(4-10) and its synthetic analog semax by rat serum enzymes: an inhibitor study. Peptides 14:491-495
193. Castrucci AM, Hadley ME, Sawyer TK, Hruby VJ 1984 Enzymological studies of melanotropins. Comp Biochem Physiol 78:519-524
194. Marks N, Stern F, Kastin AJ 1976 Biodegradation of α-MSH and derived peptides by rat brain extracts, and by rat and human serum. Brain Res Bull 1:591-593
195. Trochard MC, Vaudry H, Leboulenger F, Usategui R, Vaillant R 1976 The degradation of radioiodinated α MSH in vitro: effect of some inhibitors of proteolytic enzymes. C R Seances Soc Biol Fil 170:1103-1109
196. Deschodt-Lanckman M, Vanneste Y, Loir B, Michel A, Libert A, Ghanem G, Lejeune F 1990 Degradation of α-melanocyte stimulating hormone (α-MSH) by CALLA/endopeptidase 24.11 expressed by human melanoma cells in culture. Int J Cancer 46:1124-1130